Behavioral, electrophysiological, and autoradiographic experiments were done to study the second nociceptive phase in the formalin test. In initial experiments, this second phase was attenuated by 1-10 mg of the NK-1 receptor antagonist CP-99,994, given subcutaneously 10, 30, or 60 min before formalin (n Ï 8-10) and by 20 g given intrathecally 20 min after formalin (n Ï 13); the inactive isomer CP-100,263 was ineffective. In electrophysiological experiments on single dorsal horn neurons in vivo, the excitatory responses to subcutaneous formalin injection (50 l, 2.5%) were attenuated by subsequent intravenously administration of the NK-1 receptor antagonist CP-96,345 (0.5 mg/kg; n Ï 8), given 35-40 min after formalin, but not by the inactive enantiomer CP-96,344 (0.5 mg/kg; n Ï 9). Finally, autoradiographic binding of exogenous [125 I]BHsubstance P in the lumbar cord was reduced at 5 and 25 min after formalin (50 l, 1 or 5%), with an intermediate level of reduction at 12 min. These data are interpreted as evidence that the second phase of nociceptive scores in the formalin test is attributable at least partially to tonic activation of NK-1 receptors at the spinal level, whether because of a temporally limited release of substance P, for example only during the first phase, but a slow removal or breakdown of substance P, or, more likely, because of tonic release from primary afferents throughout the second phase. Irrespective of the mechanism, it can be concluded that at least some of the persistent nociceptive effects associated with peripheral inflammation, or at least those provoked by subcutaneous injection of formalin, are mediated via continuous activation of NK-1 receptors at the level of the spinal dorsal horn; this may relate directly to mechanisms underlying prolonged nociceptive pains in humans.Key words: substance P; substance P receptor; NK-1 receptor; tachykinin; substance P antagonist; 345;994; nociception; formalin test; wide dynamic range neuron; dorsal horn; spinal cord; intrathecal; binding; autoradiography The formalin test is commonly used as a model of acute and tonic pain, and sometimes even of inflammatory or chronic pain, or hyperalgesia. The nociceptive response to injection of dilute formalin into the plantar surface, usually of the hindpaw, consists of an early favoring, biting and licking of the injected paw, then a period of reduced nociceptive responses, and finally a second period of favoring and licking. More attention has been paid to mechanisms eliciting the second nociceptive phase, perhaps because some pharmacological manipulations that block the first phase tend also to block the second phase, and it has been argued that the second phase must be influenced by central changes induced during the first phase. Thus, the second nociceptive phase has been presented as a form of central sensitization. In view of evidence that lidocaine-induced block of the thoracic spinal cord fails to alter nociceptive responses in the formalin test ), it appears that at least some of the mecha...